Skip to content

Anti-inflammatory Effects of the Fiber

Anti-inflammatory and Reactive Oxygen Species (ROS) Suppressive Effects of the Fiber Supplementation to a High Fat High Carbohydrate Meal and Fiber Supplementation Alone in Obese Patients With Type 2 Diabetes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02868788
Enrollment
10
Registered
2016-08-16
Start date
2016-06-14
Completion date
2018-07-01
Last updated
2024-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Keywords

inflammation, insulin resistance, type 2 diabetes, obesity

Brief summary

This study will help elucidate the mechanism underlying the cardioprotective and anti-diabetes effect of dietary fiber by exploring a comprehensive set of inflammatory and oxidative stress markers, based on a contemporary understanding of this process. In addition, there have been very few studies that explored the immediate change in oxidative stress and incretin secretion after fiber intake. In this study, the investigators will be able assess the short term metabolic impact of dietary fiber at great details. The result will contribute to dietary recommendation or designing of fiber supplementation for prevention/treatment of diabetes, obesity and cardiovascular disease.

Detailed description

Baseline labs include complete blood count (CBC), comprehensive metabolic panel (CMP), Hemoglobin A1C, and lipid profile. All labs will be drawn in the fasting state Visit 1: Subjects will arrive after having fasted overnight (10 hours) at 7 to 7:30 am. An indwelling intravenous cannula will be placed in the anterior cubital vein for blood draws. A blood sample of the research labs and a urine sample will be collected. Blood pressure, heart rate and weight will be measured. Subjects will consume either a High Fat High Calorie (HFHC) meal or HFHC meal plus fiber (FiberOne Original cereal) according to randomization. Fiber will be consumed before and after the HFHC meal (28 grams in total, 14 grams before and after the meal). HFHC meal includes an egg muffin sandwich, a sausage muffin sandwich and two hash browns which contain 88g carbohydrate, 51 g fat (33% saturated) and 34 g protein. 35 ml of blood will be obtained at 1h , 2h, 3h and 5 h and 5 ml at 15 min,30 min,45 min,75 min and 90 min. A total of 165 ml (11 tablespoon) blood will be collected. . Visit 2: Subjects will return 1 week later after overnight fasting (10 hours) at 7 to 7:30 am. Blood pressure, heart rate and weight will be measured. Baseline blood and urine samples will be collected again and subjects will be crossed over to receive the second meal (HFHC only or HFHC with fiber). Visit details are similar to visit 1. After this, the subject will be discharged from the study.

Interventions

DIETARY_SUPPLEMENTdietary fiber

Fiber one supplement (32 grams of fiber) will be consumed with 910 Calorie HFHC meal

910 Calorie HFHC meal

Sponsors

University at Buffalo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Men and women 18 to 80 years of age 2. Non-smoker (last cigarette at least one month ago) 3. Type 2 diabetes for at least 1 year 4. Body mass index \> 30 kg/m2

Exclusion criteria

1. Participation in any other concurrent clinical trials 2. Pregnancy or premenopausal women who are trying to be pregnant 3. Patients who are incompetent to give consent 4. Patients on non-steroidal anti-inflammatory drugs or steroids 5. Concurrent disease that could disrupt intestinal epithelium and increase permeability to endotoxin, ie Celiac and Crohns disease. 6. Hepatic disease (transaminase \> 3 times normal) 7. Renal impairment (serum creatinine \> 1.5 mg/dl) 8. History of drug or alcohol abuse 9. Use of over the counter or prescribed probiotic supplements. 10. Recent or current antibiotic use. 11. Coronary artery disease (CAD): documented by history of myocardial infarction, angioplasty/stent placement, angina, exercise EKG positive for ischemia or angiographic evidence of CAD

Design outcomes

Primary

MeasureTime frameDescription
Peak Change in From Baseline in Reactive Oxygen Species (ROS) Generation5hrmononuclear cells will be isolated by Ficoll-Hypaque method and ROS will be measured by chemiluminescence as an index of NADPH oxidase activation. Measurment will take place at baseline before the meal intervention and hourly for 5 hrs after the meal. The percent change from baseline at peak effect will be calculated.

Secondary

MeasureTime frameDescription
Peak Change in From Baseline in Nuclear Factor-Kappa B (NFkB) Activation5hrNuclear factor-Kappa B (NFkB) activation will be measured at baseline before the meal and hourly up to 5 hrs and percent change from baseline at peak effect is calculated
Percent Change Toll Like Receptor-4 (TLR-4) Levels5hrToll Like Receptor-4 will be measured by Western Blots at baseline before meal intake and hourly up to 5 hrs after meal. Percent change from baseline at peak effect is calculated.
Change in Plasma Lipopolysaccharides Level From Baseline.5hrLipopolysaccharide will be measured by commercially available kit (Cambrex Limulus Amebocyte Lysate kit, Lonza Inc. Walkersville, MD). Measurements will take place at baseline before the meals and hourly for next 5 hrs. Percent change from baseline at peak effect is calculated.

Countries

United States

Participant flow

Participants by arm

ArmCount
Overall Study Participants
All participants will randomly receive HFHC meal with or without dietary fiber supplementation in first visit and the other intervention in the second visit. Total 10 participants in cross-over design study
10
Total10

Baseline characteristics

CharacteristicOverall Study Participants
Age, Continuous70 years
STANDARD_DEVIATION 5
Body mass index (BMI)34 Kg/m^2
STANDARD_DEVIATION 4
Race and Ethnicity Not Collected— Participants
Sex: Female, Male
Female
4 Participants
Sex: Female, Male
Male
6 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 100 / 10
other
Total, other adverse events
0 / 100 / 10
serious
Total, serious adverse events
0 / 100 / 10

Outcome results

Primary

Peak Change in From Baseline in Reactive Oxygen Species (ROS) Generation

mononuclear cells will be isolated by Ficoll-Hypaque method and ROS will be measured by chemiluminescence as an index of NADPH oxidase activation. Measurment will take place at baseline before the meal intervention and hourly for 5 hrs after the meal. The percent change from baseline at peak effect will be calculated.

Time frame: 5hr

ArmMeasureValue (MEAN)Dispersion
High Fat High CaloriePeak Change in From Baseline in Reactive Oxygen Species (ROS) Generation224 percentage of changeStandard Error 15
High Fat High Calorie Plus FiberPeak Change in From Baseline in Reactive Oxygen Species (ROS) Generation167 percentage of changeStandard Error 13
Secondary

Change in Plasma Lipopolysaccharides Level From Baseline.

Lipopolysaccharide will be measured by commercially available kit (Cambrex Limulus Amebocyte Lysate kit, Lonza Inc. Walkersville, MD). Measurements will take place at baseline before the meals and hourly for next 5 hrs. Percent change from baseline at peak effect is calculated.

Time frame: 5hr

ArmMeasureValue (MEAN)Dispersion
High Fat High CalorieChange in Plasma Lipopolysaccharides Level From Baseline.124 percentage of changeStandard Error 10
High Fat High Calorie Plus FiberChange in Plasma Lipopolysaccharides Level From Baseline.128 percentage of changeStandard Error 11
Secondary

Peak Change in From Baseline in Nuclear Factor-Kappa B (NFkB) Activation

Nuclear factor-Kappa B (NFkB) activation will be measured at baseline before the meal and hourly up to 5 hrs and percent change from baseline at peak effect is calculated

Time frame: 5hr

ArmMeasureValue (MEAN)Dispersion
High Fat High CaloriePeak Change in From Baseline in Nuclear Factor-Kappa B (NFkB) Activation124 percentage of changeStandard Error 14
High Fat High Calorie Plus FiberPeak Change in From Baseline in Nuclear Factor-Kappa B (NFkB) Activation109 percentage of changeStandard Error 8
Secondary

Percent Change Toll Like Receptor-4 (TLR-4) Levels

Toll Like Receptor-4 will be measured by Western Blots at baseline before meal intake and hourly up to 5 hrs after meal. Percent change from baseline at peak effect is calculated.

Time frame: 5hr

ArmMeasureValue (MEAN)Dispersion
High Fat High CaloriePercent Change Toll Like Receptor-4 (TLR-4) Levels181 percentage of changeStandard Error 15
High Fat High Calorie Plus FiberPercent Change Toll Like Receptor-4 (TLR-4) Levels135 percentage of changeStandard Error 12

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026